Xadago OverviewSafinamide (INN; brand name Xadago) is a drug used as an add-on treatment for Parkinson's disease during "off" episodes; it has monoamine oxidase B inhibiting and other methods of action. It was approved in Europe in February 2015, and in the United States in March 2017. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Overdose 5 Interactions 6 Pharmacology 6.1 Mechanisms of action 6.2 Pharmacokinetics 7 History 8 Research 9 See also 10 References ...
Read more Xadago Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Safinamide
Recent Xadago Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 100mg, 50mg